These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Influence of structure on the reduction of nitroxide MRI contrast-enhancing agents by ascorbate. Keana JF; Van Nice FL Physiol Chem Phys Med NMR; 1984; 16(6):477-80. PubMed ID: 6537509 [TBL] [Abstract][Full Text] [Related]
4. Probing the intracellular redox status of tumors with magnetic resonance imaging and redox-sensitive contrast agents. Hyodo F; Matsumoto K; Matsumoto A; Mitchell JB; Krishna MC Cancer Res; 2006 Oct; 66(20):9921-8. PubMed ID: 17047054 [TBL] [Abstract][Full Text] [Related]
5. Comparison study of intraarticular and intravenous gadolinium-enhanced magnetic resonance imaging of cartilage in a canine model. Kwack KS; Cho JH; Kim M MS; Yoon CS; Yoon YS; Choi JW; Kwon JW; Min BH; Sun JS; Kim SY Acta Radiol; 2008 Feb; 49(1):65-74. PubMed ID: 17963083 [TBL] [Abstract][Full Text] [Related]
7. A nitroxides-based macromolecular MRI contrast agent with an extraordinary longitudinal relaxivity for tumor imaging via clinical T1WI SE sequence. Guo S; Wang X; Li Z; Pan D; Dai Y; Ye Y; Tian X; Gu Z; Gong Q; Zhang H; Luo K J Nanobiotechnology; 2021 Aug; 19(1):244. PubMed ID: 34391417 [TBL] [Abstract][Full Text] [Related]
8. Amphiphilic branched polymer-nitroxides conjugate as a nanoscale agent for potential magnetic resonance imaging of multiple objects in vivo. Wang X; Guo S; Li Z; Luo Q; Dai Y; Zhang H; Ye Y; Gong Q; Luo K J Nanobiotechnology; 2021 Jul; 19(1):205. PubMed ID: 34243760 [TBL] [Abstract][Full Text] [Related]
9. Selective visualization of rabbit knee cartilage using MR imaging with a double-contrast agent. Kido M; Ikoma K; Hara Y; Matsuda K; Kawata M; Umeda M; Kubo T J Magn Reson Imaging; 2014 May; 39(5):1186-90. PubMed ID: 24123630 [TBL] [Abstract][Full Text] [Related]
10. In vitro toxicity in long-term cell culture of MR contrast agents targeted to cartilage evaluation. Midura S; Schneider E; Sakamoto FA; Rosen GM; Winalski CS; Midura RJ Osteoarthritis Cartilage; 2014 Sep; 22(9):1337-45. PubMed ID: 25046535 [TBL] [Abstract][Full Text] [Related]
11. Gadolinium-labeled peptide dendrimers with controlled structures as potential magnetic resonance imaging contrast agents. Luo K; Liu G; She W; Wang Q; Wang G; He B; Ai H; Gong Q; Song B; Gu Z Biomaterials; 2011 Nov; 32(31):7951-60. PubMed ID: 21784511 [TBL] [Abstract][Full Text] [Related]
13. Glycosaminoglycan in articular cartilage: in vivo assessment with delayed Gd(DTPA)(2-)-enhanced MR imaging. Bashir A; Gray ML; Boutin RD; Burstein D Radiology; 1997 Nov; 205(2):551-8. PubMed ID: 9356644 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of Gd(III)DTPA-terminated poly(propylene imine) dendrimers as contrast agents for MR imaging. Langereis S; de Lussanet QG; van Genderen MH; Meijer EW; Beets-Tan RG; Griffioen AW; van Engelshoven JM; Backes WH NMR Biomed; 2006 Feb; 19(1):133-41. PubMed ID: 16450331 [TBL] [Abstract][Full Text] [Related]
15. Cellular accumulation and antioxidant activity of acetoxymethoxycarbonyl pyrrolidine nitroxides. Dikalov SI; Dikalova AE; Morozov DA; Kirilyuk IA Free Radic Res; 2018 Mar; 52(3):339-350. PubMed ID: 29098905 [TBL] [Abstract][Full Text] [Related]
16. T2 of articular cartilage in the presence of Gd-DTPA2-. Nieminen MT; Menezes NM; Williams A; Burstein D Magn Reson Med; 2004 Jun; 51(6):1147-52. PubMed ID: 15170834 [TBL] [Abstract][Full Text] [Related]
17. Peptide-conjugated polyamidoamine dendrimer as a nanoscale tumor-targeted T1 magnetic resonance imaging contrast agent. Han L; Li J; Huang S; Huang R; Liu S; Hu X; Yi P; Shan D; Wang X; Lei H; Jiang C Biomaterials; 2011 Apr; 32(11):2989-98. PubMed ID: 21277017 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and relaxometry of high-generation (G = 5, 7, 9, and 10) PAMAM dendrimer-DOTA-gadolinium chelates. Bryant LH; Brechbiel MW; Wu C; Bulte JW; Herynek V; Frank JA J Magn Reson Imaging; 1999 Feb; 9(2):348-52. PubMed ID: 10077036 [TBL] [Abstract][Full Text] [Related]
19. Modification of nitroxyl contrast agents with multiple spins and their proton T(1) relaxivity. Matsumoto K; Yakumaru H; Narazaki M; Nakagawa H; Anzai K; Ikehira H; Ikota N Magn Reson Imaging; 2008 Jan; 26(1):117-21. PubMed ID: 17683889 [TBL] [Abstract][Full Text] [Related]
20. Intrathecal administration of nitroxides as potential contrast agents for MR imaging. Rosen GM; Griffeth LK; Brown MA; Drayer BP Radiology; 1987 Apr; 163(1):239-43. PubMed ID: 3823443 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]